Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by MikeStock on Jun 29, 2021 8:06am

Only 12 employees

It's clear Antibe isn't going to win a writing award for their new releases any time soon. They err on the side of being too vague and in the case of yesterday, I think they missed an opportunity to create more excitement around what they are doing.

I think another thing we often forget, is this is a 12 person company. We want them to move at the speed of light and get things done but if you put that into perspective, I guess they’re not doing too badly.
Comment by WalkOverTheStrt on Jun 29, 2021 9:06am
That's a cop out... They need to hire more people if they can't keep schedule if it is due to delays on their end (collecting data, analyzing data, creating apporval submissions for FDA) vs FDA review delays ... they have had additional funding for a few months now... build the team to execute and start acting like a biotech that has a PH3 multl billion dollar drug...
Comment by Straylight on Jun 29, 2021 9:53am
Well if you want to scale up hiring people is great. But you know what is even faster? Hiring a company that has the staff and systems in place to hit the ground running. Maybe they should find a company to work with like that?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities